In Re Icn Pharmaceuticals, Inc., Securities Lit.

In Re ICN Pharmaceuticals, Inc., Securities Litigation

Good Law
299 F. Supp. 2d 1055·2004 WL 42583·2004 U.S. Dist. LEXIS 4218
United States District Court, Central District of CaliforniaJanuary 5, 2004SACV 02-701 DOCCalifornia5,563 words

Opinion

Opinion

Carter, J.

ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS PLAINTIFFS’ FIRST AMENDED COMPLAINT

Before the Court is Defendants ICN Pharmaceuticals, Ine.’s, Richard Meier’s, John Giordani’s and Bill MacDonald’s motion to dismiss Plaintiffs’ consolidated amended complaint. Defendants Milan Panic and PriceWaterhouse Coopers also make separate motions to dismiss Plaintiffs’ consolidated amended complaint. After reviewing the moving, opposing and replying papers, hearing oral argument, and for reasons set forth below, the Court GRANTS the motions and (1) dismisses Plaintiffs’ complaint as to Defendants ICN Pharmaceuticals, Inc, Richard Meier, John Giordani, Bill MacDonald, and Milan Panic with leave to amend; and (2) dismisses Plaintiffs’ complaint as to Defendant Price Waterhouse Coopers without leave to amend. Accordingly, the motion by Defendants ICN Pharmaceuticals, Richard Meier, John Giordani, and Bill MacDonald, joined by Defendant Milan Panic to strike certain allegations from the complaint is DENIED as MOOT. Also, the motion by lead Plaintiff to file a memorandum of law in opposition to Defendants’ motion to strike is DENIED as MOOT.

I. BACKGROUND

This action is brought under Sections…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.